
Stockholm, May 26, 2011 - NASDAQ OMX (NASDAQ:NDAQ) announces that Moberg Derma AB (ticker symbol: MOB), a small cap company within the Health Care sector, today starts trading of its shares on the main market of NASDAQ OMX Stockholm. Moberg Derma is the fourth company to list at NASDAQ OMX European markets in 2011.
Moberg Derma is a Swedish pharmaceutical company, which in five years has created an interesting product and project portfolio with annual sales potential exceeding SEK 3 billion at the distribution level. The portfolio covers approved and launched products to projects in the preclinical phase. Moberg Derma's business idea is to develop patented topical pharmaceuticals for treatment of commonly prevailing diseases by using innovative drug delivery. Moberg Dermas products are based on proven compounds, which reduce time to market, development costs and risk. For more information visit: www.mobergderma.se.
Peter Wolpert, CEO and founder of Moberg Derma commented, ""Moberg Derma has developed faster than anticipated. We have rapidly gone from a development company to becoming a growth company. It is pleasing that investors have appreciated our focus on innovative development based on proven compounds and the value of having products on the market."
Jenny Rosberg, Senior Vice President at NASDAQ OMX said, "We are excited to welcome Moberg Derma to NASDAQ OMX and our health care sector where we see a strong inflow of companies right now. We look forward to following Moberg Derma's growth and expansion in a listed environment and to support them with the increased investor awareness that comes with a main market listing."
About NASDAQ OMX
The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with approximately 3,600 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit http://www.nasdaqomx.com. Please follow NASDAQ OMX on Facebook (http://www.facebook.com/nasdaqomx) and Twitter (http://www.twitter.com/nasdaqomx).
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about NASDAQ OMX's products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
NASDAQ OMX Media contacts:
Carl Norell +46 (8) 405 66 39
carl.norell@nasdaqomx.com